ChemoCentryx Inc(CCXI:US)

Market Cap$593.76M

Key Metrics

Price$10.66

Revenue (TTM)-

Holders Revenue (TTM)-

Gross Profit (TTM)-

Earnings (TTM)-

EBITDA (TTM)-

Op. Margin (TTM)-

Dividend Yield-

Holders Yield-

Cash on hand$410.1K

Total Assets$419.11M

Net Assets$402.96M

Total Debt$0

ChemoCentryx Inc(CCXI:US)

Market Cap$593.76M

Price history

Key Metrics

Price$10.66

Revenue (TTM)-

Holders Revenue (TTM)-

Gross Profit (TTM)-

Earnings (TTM)-

EBITDA (TTM)-

Op. Margin (TTM)-

Dividend Yield-

Holders Yield-

Cash on hand$410.1K

Total Assets$419.11M

Net Assets$402.96M

Total Debt$0

Financials

NameMar 31, 2026Sep 30, 2025Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021
Revenue
$0$0$11.76M$5.46M$2.29M$17.69M
Cost of Revenue
--$803K$205K$302K-
Gross Profit
--$10.96M$5.25M$1.99M-
$373.67K$50.93K$42.53M$43.49M$42.04M$39.49M
Research and Development--$14.36M$17.48M$18.77M$19.95M
Selling, General, and Administrative$373.67K$50.93K$28.18M$26.01M$23.29M$19.6M
Other Operating Expenses-----$28K-$52K
Operating Income
-$373.67K-$50.93K-$31.57M-$38.23M-$40.05M-$21.8M
$3.55M--$77K-$750K-$954K-$504K
Non-Operating Interest Income$3.55M-$509K$222K$166K$164K
Non-Operating Interest Expense--$586K$597K$643K$668K
Other Income/Expense----$375K-$477K-
Income Before Tax
$3.17M-$50.93K-$31.65M-$38.61M-$40.53M-$22.31M
Income Tax
------
Net Income
$3.17M-$50.93K-$31.65M-$38.61M-$40.53M-$22.31M
Minority Interests
------
Preferred Stock Dividends
------
Net Income to Common
$3.17M-$50.93K-$31.65M-$38.61M-$40.53M-$22.31M
Shares Outstanding (Basic)
55.7M46.5M71.23M70.84M70.11M69.89M
Shares Outstanding (Diluted)
55.7M46.5M71.23M70.84M70.11M69.89M
EPS (Basic)
$0.06-$0.0011-$0.44-$0.55-$0.58-$0.32
EPS (Diluted)
$0.06-$0.0011-$0.44-$0.55-$0.58-$0.32
EBIT
-$373.67K-$50.93K----
EBITDA
-$373.67K-$50.93K-$30.04M-$36.99M-$38.87M-$20.64M